A coalition of over 100 cancer groups is urging Congress to include the Clinical Treatment Act (HR-913) in an upcoming health care extenders package, scheduled to be considered this spring.
With major leadership changes, grant disruptions and terminations, and a stoked distrust in science, Steven Artandi, the director of Stanford Cancer Center, worries that young investigators will feel disenchanted by the U.S. research atmosphere and take their work and study elsewhere.
